A detailed history of Mtm Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mtm Investment Management, LLC holds 25,259 shares of BMY stock, worth $1.46 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
25,259
Previous 25,305 0.18%
Holding current value
$1.46 Million
Previous $1.05 Million 24.48%
% of portfolio
0.54%
Previous 0.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$39.66 - $51.75 $1,824 - $2,380
-46 Reduced 0.18%
25,259 $1.31 Million
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $124,976 - $164,533
-3,105 Reduced 10.93%
25,305 $1.05 Million
Q1 2024

Apr 25, 2024

SELL
$47.98 - $54.4 $7,149 - $8,105
-149 Reduced 0.52%
28,410 $1.54 Million
Q4 2023

Jan 16, 2024

SELL
$48.48 - $57.85 $29,039 - $34,652
-599 Reduced 2.05%
28,559 $1.47 Million
Q3 2023

Oct 26, 2023

BUY
$57.89 - $64.73 $57 - $64
1 Added 0.0%
29,158 $1.69 Million
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $63 - $70
1 Added 0.0%
29,157 $1.86 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $89,434 - $105,903
-1,306 Reduced 4.29%
29,156 $2.1 Million
Q3 2022

Oct 27, 2022

BUY
$0.13 - $76.84 $0 - $76
1 Added 0.0%
30,462 $2.17 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $9,898 - $11,868
-161 Reduced 0.53%
30,461 $2.23 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $35,932 - $41,888
-670 Reduced 2.14%
30,622 $1.91 Million
Q3 2021

Oct 22, 2021

SELL
$59.17 - $69.31 $144,374 - $169,116
-2,440 Reduced 7.23%
31,292 $1.85 Million
Q2 2021

Jul 20, 2021

BUY
$61.91 - $67.42 $188,268 - $205,024
3,041 Added 9.91%
33,732 $2.25 Million
Q1 2021

Apr 19, 2021

BUY
$59.34 - $66.74 $151,376 - $170,253
2,551 Added 9.07%
30,691 $1.94 Million
Q4 2020

Jan 27, 2021

BUY
$57.74 - $65.43 $1.62 Million - $1.84 Million
28,140 New
28,140 $1.75 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mtm Investment Management, LLC Portfolio

Follow Mtm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mtm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mtm Investment Management, LLC with notifications on news.